Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
T Cell
100%
Immunotherapy
81%
Mouse
79%
Tumor Antigen
43%
Cancer Immunotherapy
39%
Tumor-Infiltrating Lymphocytes
37%
Chronic Graft Versus Host Disease
36%
Immunosuppressive Drug
35%
Immune Response
33%
Cytotoxic T-Cell
32%
Epitope
32%
Mouse Model
28%
Cancer Cell
24%
Immunosuppression
24%
Myeloid
22%
Dendritic Cell
20%
Vaccination Policy
18%
Tumor Cell
18%
Vaccine Efficacy
17%
Overall Survival
17%
Natural Killer Cell
17%
Melanoma Cell
16%
Melanoma Antigen
16%
Lymphokine
16%
Peptide Vaccine
15%
Major Histocompatibility Complex
15%
Cytotoxic T Cell
15%
Immune Checkpoint Blockade
14%
Interleukin 2
14%
Homeobox
14%
Glioma Cell
14%
Tumor Suppressor Gene
14%
Transgenics
14%
Cancer Stem Cell
14%
Human Leukocyte Antigen
14%
Autoantibodies
14%
CD8
13%
Graft-Versus-Host Disease
13%
Oncogene
13%
Fibroblast
12%
Angiogenesis
12%
Macrophage
12%
MHC Class I
11%
Tumor Immunity
11%
HLA A24 Antigen
11%
Vasculotropin
11%
Tumor-Associated Macrophage
11%
FOXP3
11%
Autophagy
10%
Peripheral Blood Mononuclear Cell
10%
Cell Infiltration
10%
B Cell
10%
Endoplasmic Reticulum Stress
9%
Mononuclear Cell
9%
Syngenic
9%
Null Cell
9%
Immunogenicity
9%
Colon
9%
Interleukin 6
8%
CCL17
8%
P53
8%
Transgenic Mouse
8%
Microsatellite Instability
8%
CD4
8%
Lacrimal Gland
8%
Cell Population
7%
Idiopathic Thrombocytopenic Purpura
7%
Lymph Node
7%
Transcription Factors
7%
Surface Property
7%
interferon
7%
Vaccine Therapy
7%
Wart Virus
7%
Tranilast
7%
Interleukin 3
7%
CD155
7%
Mycobacterium Bovis BCG
7%
Tear Film
7%
Chimeric Antigen Receptor T-Cell
7%
Melanocyte Protein Pmel 17
7%
Scleroderma
7%
Fibroblast Growth Factor 9
7%
Promoter Region
7%
T Cell Activation
7%
G 207
7%
Renin Angiotensin Aldosterone System
7%
Migration Inhibition Factor
7%
Systemic Scleroderma
7%
Dendritic Cell Vaccine
7%
Stem Cell
7%
Interleukin 15
7%
CpG Island
7%
Vesicle-Associated Membrane Protein 8
7%
Encephalomyocarditis Virus
7%
Carcinoma Cell
7%
Systemic Lupus Erythematosus
7%
CD40 Ligand
7%
T-Helper Cell
7%
Interleukin-6
6%
Antigen Specificity
6%
Medicine and Dentistry
Nodular Melanoma
51%
Neoplasm
49%
T Cell
44%
Immunotherapy
40%
Ganglioglioma
29%
Malignant Neoplasm
29%
Cancer Immunotherapy
24%
Cytotoxic T-Cell
20%
Metastatic Carcinoma
17%
Cancer Cell
17%
Epitope
16%
Glioma Cell
16%
Lymphokine
16%
Tumor Infiltrating Lymphocyte
15%
Immune Response
15%
Tumor Antigen
14%
Metastatic Melanoma
14%
Tumor Suppressor Gene
14%
Tear Film
14%
Tumor Cell
13%
Tumor Microenvironment
13%
Immune Checkpoint Inhibitor
12%
Immunosuppressive Drug
12%
Cell Therapy
11%
Immunoglobulin
11%
Clinical Trial
11%
Recurrent Disease
11%
Biological Marker
11%
Colon Cancer
10%
Downregulation
10%
Kinesin
10%
CD8 Antigen
9%
Glycoprotein Gp 100
9%
Oncogene
9%
Null Cell
9%
Cellular Infiltration
9%
Melanoma Cell
8%
Programmed Death-Ligand 1
8%
Immune Checkpoint Blockade
8%
Programmed Cell Death
8%
Microsatellite Instability
8%
Dendritic Cell
8%
Angiogenesis
8%
HLA-A
8%
Pancreas Cancer
8%
Lymph Node Metastasis
7%
T-Helper Cell
7%
Cancer Testis Antigen
7%
Peptide Vaccine
7%
Overall Survival
7%
Translational Research
7%
Vascular Adhesion Protein-1
7%
Wart Virus
7%
Chronic Myelogenous Leukemia
7%
RNA Polymerase I
7%
Solid Malignant Neoplasm
7%
Homeodomain Protein
7%
Restriction Landmark Genomic Scanning
7%
Mononuclear Cell
7%
CHD7
7%
Skin Tumor
7%
Human Leukocyte Antigen
7%
Chronic Graft Versus Host Disease
7%
Hemangiopericytoma
7%
Neural Crest Cell
7%
Promoter Region
7%
Metastatic Bladder Cancer
7%
Dronabinol
7%
Transcription Factors
7%
Homeobox
7%
Docetaxel
7%
Cancer Stem Cell
7%
Interleukin 2
7%
Clinical Significance
7%
Autophagy
7%
Syndrome CHARGE
7%
Esophageal Cancer
7%
Squamous Cell Carcinoma
7%
Solitary Fibrous Tumor
7%
Dendritic Cell Vaccine
7%
Major Histocompatibility Complex
7%
Cyclin-Dependent Kinase
7%
Idiopathic Thrombocytopenic Purpura
7%
Induced Pluripotent Stem Cell
7%
Endometrial Cancer
7%
Clear Cell Renal Cell Carcinoma
7%
Interleukin 3
7%
Paclitaxel
7%
Myeloid Cell
7%
Cervical Cancer
7%
Carboplatin
7%
Brain Tumor
7%
Encephalomyocarditis Virus
7%
Ocular Surface
7%
Bowen's Disease
7%
Dry Eye
7%
Eye Disease
7%
Disease Model
7%
Complementary DNA
7%
Brain Tissue
6%
Keyphrases
Graft-versus-host Disease (GvHD)
37%
Tumor-infiltrating Lymphocytes
14%
Immune Response
11%
Tyrosine Kinase Inhibitor
11%
Endoplasmic Reticulum Stress (ER stress)
9%
Melanoma Antigens
9%
Autoantibodies
9%
4-phenylbutyric Acid (4-PBA)
9%
Extramammary Paget's Disease
9%
Peripheral Blood Mononuclear Cells
8%
Thrombocytopenia
8%
Lacrimal Gland
8%
Immune Targets
8%
Thrombotic Thrombocytopenic Purpura
7%
Dry Eye
7%
Reducer
7%
Melanoma
7%
Poxvirus Vectors
7%
Translational Research
7%
Immune Checkpoint Therapy
7%
Cancer Vaccine Therapy
7%
BCG-CWS
7%
Wilms' Tumor Gene
7%
Skin Tumor
7%
Leukemia Patients
7%
Cancer-testis Antigen
7%
Regulatory Factor X1 (RFX1)
7%
Chronic Myeloid Leukemia
7%
TIGIT
7%
Voltage-gated Potassium Channel
7%
Randomized Phase II Trial
7%
NUAK2
7%
CD155
7%
Human Immune System
7%
Laboratory Applications
7%
KIF23
7%
MHC Class II
7%
Myasthenia Gravis
7%
Prognostic Study
7%
Accuracy Study
7%
Human Melanocytes
7%
PTEN Deficiency
7%
Melanocyte Stem Cell
7%
Severe Disease
7%
Non-small Cell Lung Cancer (NSCLC)
7%
PTPL1
7%
RhoA-ROCK
7%
Neurogenic Potential
7%
Cisplatin
7%
Nivolumab
7%
Dendritic Cell Vaccine
7%
Anti-topoisomerase I Antibodies
7%
Topoisomerase
7%
Epidermal Growth Factor Receptor Gene
7%
Non-squamous
7%
Treatment-free Remission
7%
Putative Drug Targets
7%
Brain Tumor-initiating Cells
7%
MHC Class I
7%
Metastatic Bladder Cancer
7%
Kinesin Family Member 20A
7%
Lymphocyte Proliferation
7%
Therapeutic Peptides
7%
Anatomic Site
7%
Sclerodermatous Chronic Graft-versus-host Disease
7%
XAGE-1b
7%
NY-ESO-1
7%
Single Patient
7%
Kv1.4
7%
G207
7%
Pemetrexed
7%
Heat Shock Protein 47
7%
Reduced Expression
7%
NOG Mice
7%
Migration Inhibitory Factor
7%
Microsatellite Instability-high (MSI-H)
7%
Systemic Sclerosis
7%
Intracranial Solitary Fibrous Tumor/hemangiopericytoma
7%
Healthy Skin
7%
CCL17
7%
Therapeutic Potential
7%
Bone Marrow Stromal Stem Cells
7%
T790M mutation
7%
Esophageal Cancer
7%
Long-term Evaluation
7%
Novel Treatments
7%
Tranilast
7%
Epirubicin
7%
Tumor Reactivity
7%
Longitudinal Analysis
7%
Endometrial Cancer
7%
UPARAP
7%
Paclitaxel
7%
Immunosuppressive Myeloid Cells
7%
Human Lymphocytes
7%
Metastatic Melanoma
7%
Interleukin-2
7%
Lymphokine-activated Killers
7%
Immunocheckpoint
7%
Systemic Lupus Erythematosus
7%